Hanmi Pharmaceutical, Co., Ltd., headquartered in Seoul, South Korea, and established in 1973, has become one of the largest companies not only in Korea but also within the region, selling over 200 products worldwide. Today, Hanmi is also recognized as the No.1 R&D investing company in Korea, spending over 10~15% of the company’s annual revenue in developing next generation Platform Technologies & NCE products. For further information about Hanmi Pharmaceutical, please visit our website at www.hanmipharm.com.
| Website | http://www.hanmi.co.kr/ |
| Revenue | $7.9 million |
| Employees | 506 (167 on RocketReach) |
| Founded | 1973 |
| Phone | +82 31-371-5027 |
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals |
| Competitors | Samsung Biologics, LG Chem, Celltrion Inc, Daewoong Pharmaceutical, Hanmi Pharmaceuticals, GSK, Merck & Co., Inc., Amgen, Novartis, Boehringer Ingelheim +39 more (view full list) |
Looking for a particular Hanmi Pharmaceuticals employee's phone or email?
The Hanmi Pharmaceuticals annual revenue was $7.9 million in 2026.
Chang-Ju Choi is the Vice President, Information Management Team and IR Committee of Hanmi Pharmaceuticals.
167 people are employed at Hanmi Pharmaceuticals.